103 related articles for article (PubMed ID: 7830105)
21. Chemo-biotherapy with 5-fluorouracil, leucovorin, and alpha interferon in metastatic carcinoma of the colon--a Cancer Biotherapy Research Group [CBRG] phase II study.
Soori GS; Oldham RK; Dobbs TW; Bury MJ; Church CK; DePriest C
Cancer Biother Radiopharm; 2000 Apr; 15(2):175-83. PubMed ID: 10803323
[TBL] [Abstract][Full Text] [Related]
22. Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council.
Seymour MT; Slevin ML; Kerr DJ; Cunningham D; James RD; Ledermann JA; Perren TJ; McAdam WA; Harper PG; Neoptolemos JP; Nicholson M; Duffy AM; Stephens RJ; Stenning SP; Taylor I
J Clin Oncol; 1996 Aug; 14(8):2280-8. PubMed ID: 8708718
[TBL] [Abstract][Full Text] [Related]
23. Phase II trial of 5-fluorouracil and leucovorin in combination with interferon-alpha and interleukin-2 for advanced renal cell cancer.
Rathmell WK; Malkowicz SB; Holroyde C; Luginbuhl W; Vaughn DJ
Am J Clin Oncol; 2004 Apr; 27(2):109-12. PubMed ID: 15057147
[TBL] [Abstract][Full Text] [Related]
24. Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer.
Nobile MT; Barzacch MC; Sanguineti O; Chiara S; Gozza A; Vincenti M; Lavarello A; Cognein P; Lionetto R; Percivale PL; Bertoglio S; Murolo C; Esposito M; Vannozzi MO; Rosso R
Anticancer Res; 1998; 18(1B):517-21. PubMed ID: 9568171
[TBL] [Abstract][Full Text] [Related]
25. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and tolerability of oxaliplatin plus irinotecan 5-fluouracil and leucovorin regimen in advanced stage colorectal cancer patients pretreated with irinotecan 5-fluouracil and leucovorin.
Stathopoulos GP; Rigatos SK; Stathopoulos JG; Xynotroulas JP; Dimou E
Am J Clin Oncol; 2005 Dec; 28(6):565-9. PubMed ID: 16317265
[TBL] [Abstract][Full Text] [Related]
27. Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer.
Buroker TR; O'Connell MJ; Wieand HS; Krook JE; Gerstner JB; Mailliard JA; Schaefer PL; Levitt R; Kardinal CG; Gesme DH
J Clin Oncol; 1994 Jan; 12(1):14-20. PubMed ID: 7677801
[TBL] [Abstract][Full Text] [Related]
28. Subcutaneous low-dose interleukin-2 and intravenous 5-fluorouracil plus high-dose levofolinic acid as salvage treatment for metastatic colorectal carcinoma.
Gebbia V; Testa A; Majello E; Cannata G; Tirrito ML; Mastrandrea G; Feo M; Bajardi G; Colucci G; Gebbia N
Anticancer Drugs; 1996 Jun; 7(4):386-91. PubMed ID: 8826605
[TBL] [Abstract][Full Text] [Related]
29. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.
Jäger E; Heike M; Bernhard H; Klein O; Bernhard G; Lautz D; Michaelis J; Meyer zum Büschenfelde KH; Knuth A
J Clin Oncol; 1996 Aug; 14(8):2274-9. PubMed ID: 8708717
[TBL] [Abstract][Full Text] [Related]
30. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
Hudes GR; Lipsitz S; Grem J; Morrisey M; Weiner L; Kugler JW; Benson A
Cancer; 1999 Jan; 85(2):290-4. PubMed ID: 10023694
[TBL] [Abstract][Full Text] [Related]
31. Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon-alpha-2c in patients with advanced colorectal cancer: final results of a randomised phase III study.
Hausmaninger H; Moser R; Samonigg H; Mlineritsch B; Schmidt H; Pecherstorfer M; Fridrik M; Kopf C; Nitsche D; Kaider A; Ludwig H
Eur J Cancer; 1999 Mar; 35(3):380-5. PubMed ID: 10448286
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of advanced gastric and colorectal cancer with 5-FU, leucovorin and interferon-alpha].
Tsujimura T; Ezaki K; Ono Y; Nakano H; Kawase K; Iwase K; Hatanaka T; Ohara K; Hobara R; Okamoto M
Gan To Kagaku Ryoho; 1993 Mar; 20(4):493-8. PubMed ID: 8452387
[TBL] [Abstract][Full Text] [Related]
33. Randomized phase III study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer.
Jones DV; Winn RJ; Brown BW; Levy LB; Pugh RP; Wade JL; Gross HM; Pendergrass KB; Levin B; Abbruzzese JL
Cancer; 1995 Nov; 76(10):1709-14. PubMed ID: 8625038
[TBL] [Abstract][Full Text] [Related]
34. Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer.
Poon MA; O'Connell MJ; Wieand HS; Krook JE; Gerstner JB; Tschetter LK; Levitt R; Kardinal CG; Mailliard JA
J Clin Oncol; 1991 Nov; 9(11):1967-72. PubMed ID: 1941055
[TBL] [Abstract][Full Text] [Related]
35. A phase II study of 5-fluorouracil, leucovorin and interferon-alpha in advanced pancreatic cancer.
Moore MJ; Erlichman C; Kaizer L; Fine S
Anticancer Drugs; 1993 Oct; 4(5):555-7. PubMed ID: 8292812
[TBL] [Abstract][Full Text] [Related]
36. High-dose infusional 5-fluorouracil combination therapy of metastatic gastric and colorectal cancer.
Loeffler TM; Hausamen TU
J Infus Chemother; 1996; 6(3):137-40. PubMed ID: 9229325
[TBL] [Abstract][Full Text] [Related]
37. Treatment of metastatic colorectal cancer patients with 5-fluorouracil in combination with recombinant subcutaneous human interleukin-2 and alpha-interferon.
Atzpodien J; Kirchner H; Hänninen EL; Menzel T; Deckert M; Franzke A; Schomburg A; Poliwoda H
Oncology; 1994; 51(3):273-5. PubMed ID: 8196911
[TBL] [Abstract][Full Text] [Related]
38. Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer.
Conti JA; Kemeny NE; Saltz LB; André AM; Grossano DD; Bertino JR
Cancer; 1995 Feb; 75(3):769-74. PubMed ID: 7828126
[TBL] [Abstract][Full Text] [Related]
39. Phase II study of weekly oxaliplatin and high-dose infusional 5-fluorouracil plus leucovorin in pretreated patients with metastatic colorectal cancer.
Chiara S; Nobile MT; Gozza A; Taveggia P; Heouaine A; Pastrone I; Percivale PL; Lionetto R; Sanguineti O; Rosso R
Anticancer Res; 2004; 24(1):355-60. PubMed ID: 15015621
[TBL] [Abstract][Full Text] [Related]
40. The effect of 5-fluorouracil and alpha interferon and 5-fluorouracil and leucovorin on cellular anti-tumour immune responses in patients with advanced colorectal cancer.
Nichols PH; Ward U; Ramsden CW; Primrose JN
Br J Cancer; 1994 Nov; 70(5):946-9. PubMed ID: 7947102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
